RT Journal Article
SR Electronic
T1 Testing Denmark: A Danish nationwide surveillance study of COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.08.10.21261777
DO 10.1101/2021.08.10.21261777
A1 Fogh, Kamille
A1 Strange, Jarl E
A1 Scharff, Bibi FSS
A1 Eriksen, Alexandra RR
A1 Hasselbalch, Rasmus B
A1 Bundgaard, Henning
A1 Nielsen, Susanne D
A1 Jørgensen, Charlotte S
A1 Erikstrup, Christian
A1 Norsk, Jakob
A1 Nielsen, Pernille Brok
A1 Kristensen, Jonas H
A1 Østergaard, Lars
A1 Ellermann-Eriksen, Svend
A1 Andersen, Berit
A1 Nielsen, Henrik
A1 Johansen, Isik S
A1 Wiese, Lothar
A1 Simonsen, Lone
A1 Fischer, Thea K.
A1 Folke, Fredrik
A1 Lippert, Freddy
A1 Ostrowski, Sisse R
A1 Benfield, Thomas
A1 Mølbak, Kåre
A1 Ethelberg, Steen
A1 Koch, Anders
A1 Sönksen, Ute Wolff
A1 Vangsted, Anne-Marie
A1 Krause, Tyra Grove
A1 Fomsgaard, Anders
A1 Ullum, Henrik
A1 Skov, Robert
A1 Iversen, Kasper
YR 2021
UL http://medrxiv.org/content/early/2021/08/13/2021.08.10.21261777.abstract
AB Background National data on the spread of SARS-CoV-2 infection and knowledge on associated risk factors are important for understanding the course of the pandemic. “Testing Denmark” is a national large-scale epidemiological surveillance study of SARS-CoV-2 in the Danish population.Methods Between September and October 2020, approximately 1.3 million of 5.8 million Danish citizens (age > 15 years) were randomly invited to fill in an electronic questionnaire covering COVID-19 exposures and symptoms. The prevalence of SARS-CoV-2 antibodies was determined by Point-of Care rapid Test (POCT) distributed to participants home addresses.Findings In total 318,552 participants (24.5% invitees) completed the questionnaire and provided the result of the POCT. Of these, 2,519 (0.79%) were seropositive (median age 55 years) and women were more often seropositive than men, interquartile range (IQR) 42-64, 40.2% males. Of participants with a prior positive Polymerase Chain Reaction (PCR) test (n=1,828), 29.1% were seropositive in the POCT. Seropositivity increased with age irrespective of sex. Elderly participants (>61 years) reported less symptoms and had less frequently been tested for SARS-CoV-2 compared to younger participants. Seropositivity was associated with physical contact with SARS-CoV-2 infected individuals (Risk ratio (RR) 7.43, 95% CI: 6.57-8.41) and in particular household members (RR 17.70, 95% CI: 15.60-20.10). Home care workers had a higher risk of seropositivity (RR 2.09 (95% CI: 1.58-2.78) as compared to office workers. Geographic population density was not associated to seropositivity. A high degree of compliance with national preventive recommendations was reported (e.g., > 80% use of face masks), but no difference was found between seropositive and seronegative participants.Interpretation This study provides insight into the immunity of the Danish population seven to eight months after the first COVID-19 case in Denmark. The seroprevalence was lower than expected probably due to a low sensitivity of the POCT used or due to challenges relating to the reading of test results. Occupation or exposure in local communities were major routes of infection. As elderly participants were more often seropositive despite fewer symptoms and less PCR tests performed, more emphasis should be placed on testing this age group.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by grants from the Danish Ministry of Health (2012461). The funders did not influence study design, conduct, or reporting.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was performed as a national surveillance study under the authority task of the national infectious disease control institute Statens Serum Institut (SSI), Copenhagen, Denmark. According to Danish law national surveillance activities from SSI do not require any individual approval from an ethics committee. This was in accordance with the regional ethics committee from the Capital region in Denmark (20057075), who made the above determination that the study did not require approval from an ethics committee. Participation was voluntary and all data were self-reported. Invitees received information about their legal rights and the use of their data in the invitation letter.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll personal data obtained in Enalyzer was kept in accordance with the general data protection regulation and data protection law stated by the Danish Data Protection Agency. The study was performed in agreement with the Helsinki II declaration and registered with the Danish Data Protection Authorities (P-2020-901).